BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home

Dataset: Expression data from primary hepatocytes knocking down or overexpressing IRE1a

The ER-resident protein kinase/endoribonuclease IRE1 is activated through trans-autophosphorylation in response to protein folding...

Registered by ArrayExpress Uploader
View Dataset

The ER-resident protein kinase/endoribonuclease IRE1 is activated through trans-autophosphorylation in response to protein folding overload in the ER lumen and maintains ER homeostasis by triggering a key branch of the unfolded protein response. Here we show that mammalian IRE1a in liver cells is also phosphorylated by a kinase other than itself in response to metabolic stimuli. Glucagon stimulated protein kinase PKA, which in turn phosphorylated IRE1a at Ser724, a highly conserved site within the kinase activation domain. Blocking Ser724 phosphorylation impaired the ability of IRE1a to augment the upregulation by glucagon signaling of the expression of gluconeogenic genes. Moreover, hepatic IRE1a was highly phosphorylated at Ser724 by PKA in mice with obesity, and silencing hepatic IRE1a markedly reduced hyperglycemia and glucose intolerance. Hence, these results suggest that IRE1a integrates signals from both the ER lumen and the cytoplasm in the liver and is coupled to the glucagon signaling in the regulation of glucose metabolism. We used DNA microarray to analyze the transcriptomic change upon IRE1a overexpression or IRE1a depletion in primary hepatocytes, to study the changes related to IRE1a Primary hepatocytes were infected with the desired adenoviruses (Ad-EGFP, Ad-WT, Ad-S724A, Ad-shCON, Ad-shIRE1a#2) or treated with glucagon. Total cellular RNA was isolated with TRIzol (Invitrogen) and subjected to analysis by Affymetrix Mouse Genome 430 2.0 Arrays. Three experiments were independently conducted.

Species:
mouse

Samples:
15

Source:
E-GEOD-31638

Updated:
Dec.12, 2014

Registered:
Nov.11, 2014


Factors: (via ArrayExpress)
Sample GENOTYPE/VARIATION TREATMENT
GSM785818 EGFP overexpression as control no treatment
GSM785818 EGFP overexpression as control no treatment
GSM785818 EGFP overexpression as control no treatment
GSM78582 IRE1a wildtype overexpression no treatment
GSM78582 IRE1a wildtype overexpression no treatment
GSM78582 IRE1a wildtype overexpression no treatment
GSM785824 IRE1aS724A overexpression no treatment
GSM785824 IRE1aS724A overexpression no treatment
GSM785824 IRE1aS724A overexpression no treatment
GSM785827 knocking down control treated with glucagon for 4 hours
GSM785827 knocking down control treated with glucagon for 4 hours
GSM785827 knocking down control treated with glucagon for 4 hours
GSM785830 IRE1a knocking down treated with glucagon for 4 hours
GSM785830 IRE1a knocking down treated with glucagon for 4 hours
GSM785830 IRE1a knocking down treated with glucagon for 4 hours

Tags

  • cytoplasm
  • genome
  • glucagon
  • glucose
  • glucose intolerance
  • hyperglycemia
  • liver
  • obesity
  • protein

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use